WO2004051231A1 - 分離装置および分離方法 - Google Patents
分離装置および分離方法 Download PDFInfo
- Publication number
- WO2004051231A1 WO2004051231A1 PCT/JP2003/015260 JP0315260W WO2004051231A1 WO 2004051231 A1 WO2004051231 A1 WO 2004051231A1 JP 0315260 W JP0315260 W JP 0315260W WO 2004051231 A1 WO2004051231 A1 WO 2004051231A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substance
- separation
- adsorbed
- sample
- channel
- Prior art date
Links
- 238000000034 method Methods 0.000 title description 69
- 238000000926 separation method Methods 0.000 claims abstract description 275
- 239000000126 substance Substances 0.000 claims abstract description 234
- 239000000758 substrate Substances 0.000 claims abstract description 75
- 239000007788 liquid Substances 0.000 claims abstract description 67
- 239000000463 material Substances 0.000 claims abstract description 32
- 239000000523 sample Substances 0.000 claims description 157
- 108090000623 proteins and genes Proteins 0.000 claims description 33
- 102000004169 proteins and genes Human genes 0.000 claims description 33
- 238000001035 drying Methods 0.000 claims description 32
- 125000006850 spacer group Chemical group 0.000 claims description 23
- 230000027455 binding Effects 0.000 claims description 16
- 239000003446 ligand Substances 0.000 claims description 15
- 229910052751 metal Inorganic materials 0.000 claims description 15
- 239000002184 metal Substances 0.000 claims description 15
- 238000004949 mass spectrometry Methods 0.000 claims description 14
- 108090001090 Lectins Proteins 0.000 claims description 12
- 102000004856 Lectins Human genes 0.000 claims description 12
- 239000002523 lectin Substances 0.000 claims description 12
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 239000000427 antigen Substances 0.000 claims description 8
- 102000036639 antigens Human genes 0.000 claims description 8
- 108091007433 antigens Proteins 0.000 claims description 8
- 239000003112 inhibitor Substances 0.000 claims description 7
- 239000012472 biological sample Substances 0.000 claims description 6
- 102000005962 receptors Human genes 0.000 claims description 6
- 108020003175 receptors Proteins 0.000 claims description 6
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 238000001976 enzyme digestion Methods 0.000 claims 1
- 239000000872 buffer Substances 0.000 abstract description 25
- 230000003993 interaction Effects 0.000 abstract description 17
- 239000003463 adsorbent Substances 0.000 abstract description 15
- 238000003795 desorption Methods 0.000 abstract description 7
- 238000004140 cleaning Methods 0.000 abstract 1
- 238000010586 diagram Methods 0.000 description 21
- 239000000243 solution Substances 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 14
- 102000053602 DNA Human genes 0.000 description 14
- 238000001179 sorption measurement Methods 0.000 description 12
- 238000005406 washing Methods 0.000 description 10
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 9
- 238000001042 affinity chromatography Methods 0.000 description 9
- 239000007822 coupling agent Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 229910052710 silicon Inorganic materials 0.000 description 9
- 239000010703 silicon Substances 0.000 description 9
- 239000006087 Silane Coupling Agent Substances 0.000 description 8
- 230000003100 immobilizing effect Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 7
- 108091034117 Oligonucleotide Proteins 0.000 description 7
- 239000000074 antisense oligonucleotide Substances 0.000 description 7
- 238000012230 antisense oligonucleotides Methods 0.000 description 7
- 238000010894 electron beam technology Methods 0.000 description 7
- -1 for example Substances 0.000 description 7
- 238000011002 quantification Methods 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000004925 denaturation Methods 0.000 description 6
- 230000036425 denaturation Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000005530 etching Methods 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 125000003396 thiol group Chemical group [H]S* 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 4
- BRARRAHGNDUELT-UHFFFAOYSA-N 3-hydroxypicolinic acid Chemical compound OC(=O)C1=NC=CC=C1O BRARRAHGNDUELT-UHFFFAOYSA-N 0.000 description 4
- 108090001008 Avidin Proteins 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- VTJUKNSKBAOEHE-UHFFFAOYSA-N calixarene Chemical compound COC(=O)COC1=C(CC=2C(=C(CC=3C(=C(C4)C=C(C=3)C(C)(C)C)OCC(=O)OC)C=C(C=2)C(C)(C)C)OCC(=O)OC)C=C(C(C)(C)C)C=C1CC1=C(OCC(=O)OC)C4=CC(C(C)(C)C)=C1 VTJUKNSKBAOEHE-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 229920002120 photoresistant polymer Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229910052814 silicon oxide Inorganic materials 0.000 description 4
- 239000013076 target substance Substances 0.000 description 4
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 241000725303 Human immunodeficiency virus Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000002427 irreversible effect Effects 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000005192 partition Methods 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000004381 surface treatment Methods 0.000 description 3
- XLEYFDVVXLMULC-UHFFFAOYSA-N 2',4',6'-trihydroxyacetophenone Chemical compound CC(=O)C1=C(O)C=C(O)C=C1O XLEYFDVVXLMULC-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methoxysalicylic acid Chemical compound COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 101100510326 Caenorhabditis elegans tpa-1 gene Proteins 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 125000003172 aldehyde group Chemical group 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 230000005686 electrostatic field Effects 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 150000002433 hydrophilic molecules Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 2
- 238000009832 plasma treatment Methods 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000007740 vapor deposition Methods 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- AAUQLHHARJUJEH-UHFFFAOYSA-N 2-hydroxy-5-methoxybenzoic acid Natural products COC1=CC=CC(O)=C1C(O)=O AAUQLHHARJUJEH-UHFFFAOYSA-N 0.000 description 1
- MZWXWSVCNSPBLH-UHFFFAOYSA-N 3-(3-aminopropyl-methoxy-methylsilyl)oxypropan-1-amine Chemical compound NCCC[Si](C)(OC)OCCCN MZWXWSVCNSPBLH-UHFFFAOYSA-N 0.000 description 1
- ULRCHFVDUCOKTE-UHFFFAOYSA-N 3-[3-aminopropyl(diethoxy)silyl]oxybutan-1-amine Chemical compound NCCC[Si](OCC)(OCC)OC(C)CCN ULRCHFVDUCOKTE-UHFFFAOYSA-N 0.000 description 1
- ZDZYGYFHTPFREM-UHFFFAOYSA-N 3-[3-aminopropyl(dimethoxy)silyl]oxypropan-1-amine Chemical compound NCCC[Si](OC)(OC)OCCCN ZDZYGYFHTPFREM-UHFFFAOYSA-N 0.000 description 1
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 1
- CDWGDLKZKCYUFO-UHFFFAOYSA-N 6-(trifluoromethyl)-1h-indole-2-carboxylic acid Chemical compound C1=C(C(F)(F)F)C=C2NC(C(=O)O)=CC2=C1 CDWGDLKZKCYUFO-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- BMTAFVWTTFSTOG-UHFFFAOYSA-N Butylate Chemical compound CCSC(=O)N(CC(C)C)CC(C)C BMTAFVWTTFSTOG-UHFFFAOYSA-N 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 101710096438 DNA-binding protein Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 101100377506 Drosophila melanogaster 14-3-3zeta gene Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 108010010369 HIV Protease Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 108010046516 Wheat Germ Agglutinins Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 229960000182 blood factors Drugs 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000609 electron-beam lithography Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229920001002 functional polymer Polymers 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000010884 ion-beam technique Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000000016 photochemical curing Methods 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 229940081066 picolinic acid Drugs 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 1
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 238000001269 time-of-flight mass spectrometry Methods 0.000 description 1
- YUYCVXFAYWRXLS-UHFFFAOYSA-N trimethoxysilane Chemical compound CO[SiH](OC)OC YUYCVXFAYWRXLS-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000001039 wet etching Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- AFVLVVWMAFSXCK-UHFFFAOYSA-N α-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(C#N)=CC1=CC=C(O)C=C1 AFVLVVWMAFSXCK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0039—Inorganic membrane manufacture
- B01D67/0053—Inorganic membrane manufacture by inducing porosity into non porous precursor membranes
- B01D67/006—Inorganic membrane manufacture by inducing porosity into non porous precursor membranes by elimination of segments of the precursor, e.g. nucleation-track membranes, lithography or laser methods
- B01D67/0062—Inorganic membrane manufacture by inducing porosity into non porous precursor membranes by elimination of segments of the precursor, e.g. nucleation-track membranes, lithography or laser methods by micromachining techniques, e.g. using masking and etching steps, photolithography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/14—Dynamic membranes
- B01D69/141—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/02—Inorganic material
- B01D71/024—Oxides
- B01D71/027—Silicium oxide
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502746—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means for controlling flow resistance, e.g. flow controllers, baffles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502753—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/34—Purifying; Cleaning
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0631—Purification arrangements, e.g. solid phase extraction [SPE]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/405—Concentrating samples by adsorption or absorption
Definitions
- the present invention relates to a separation device, a separation method, and a mass spectrometry system, and more particularly, to a separation device utilizing a specific interaction between substances.
- an affinity adsorbent is prepared by immobilizing a substance that has a specific interaction with the substance to be separated and purified on an insoluble carrier, and the affinity adsorbent is packed into a column and used in a sample solution.
- This is a chromatography in which the target substance is adsorbed on an affinity adsorbent and separated.
- Affinity chromatography is a method that is particularly useful for separating and purifying biological substances because it separates components using specific interactions between substances.
- affinity chromatography performed by packing the column was not necessarily suitable in terms of a design that efficiently separates a small amount of sample.
- microchips with on-chip separation and analysis functions for biological substances are being actively conducted.
- These microchips are provided with fine separation channels and the like using microfabrication technology, so that an extremely small amount of sample can be introduced into the microchip to perform separation.
- Patent Document 1 As a technology utilizing such a microchip, an attempt to introduce a technique of affinity chromatography has been proposed (Patent Document 1).
- the flow channel is provided with a region filled with an affinity adsorbent using beads or the like as a carrier.
- affinity adsorbent When a sample containing the target component flows through the flow channel, the target component is adsorbed on the affinity adsorbent. It is supposed to be.
- an affinity adsorbent is used in such a configuration. If the packing ratio is high, the affinity adsorbents cannot be sufficiently separated from each other, and the entire surface of the affinity adsorbent cannot participate in adsorption with the target substance, resulting in a decrease in separation efficiency. There was a problem.
- the device described in Patent Document 1 describes that the channel wall can be made of an insoluble carrier.However, when only the wall is used, the surface area is small, and a sufficient affinity adsorbent may be provided. Then, the length of the channel was getting longer.
- the target substance has been adsorbed on the affinity adsorbent, it is necessary to desorb and recover the substance from the affinity adsorbent.
- a solution containing a highly concentrated salt solution or an organic solvent is used,
- the target substance is a substance having a higher-order structure such as a protein, there has been a problem that irreversible denaturation or inactivation of the three-dimensional structure occurs.
- Patent Literature 1 Japanese Patent Application Publication No. 2000-502 No. Publication of the Invention
- a base material a flow path through which a sample provided on the base material flows, a separation part provided in the flow path, and separating a specific substance in the sample, and a separation part provided in the separation part And a fine flow path narrower than the flow path, characterized in that a layer of a substance to be adsorbed that is selectively adsorbed or bound to the specific substance is formed in the separation part.
- “selectively adsorbing or binding” means that only the test substance is It means that it adsorbs or binds to the detection substance and does not adsorb or bind to other substances contained in the sample. There is no limitation on the mode of adsorption or binding, and it may be a physical interaction or a chemical interaction. The selective adsorption or binding is hereinafter referred to as "specific interaction" as appropriate.
- the separation device is a device that separates a specific substance in a sample using a principle of affinity mouth chromatography in a separation section. Since the separation device according to the present invention has a configuration in which the separation section is provided in the flow path formed in the base material, when a sample containing a specific substance is introduced into the flow path, the adsorption formed in the separation section is performed. It can be selectively adsorbed or bound to a layer of material. Therefore, the specific substance can be separated by a simple operation.
- the number of molecules of the specific substance that can approach and interact with the substance to be adsorbed on the surface of the separation section can be increased. Therefore, it is possible to separate specific substances efficiently.
- the separation device can perform affinity opening on a microchip, it can be incorporated in a TAS (Micrototal Ana 1 ytica 1 System: Micrototal Analytical System). Is also possible. For example, by adopting a configuration in which the sample separated by the separation unit is connected to the sample drying unit, the separated sample can be dried and collected, and can be used for mass spectrometry and the like.
- TAS Micrototal Ana 1 ytica 1 System: Micrototal Analytical System
- a base material a flow path through which a sample provided on the base material flows, a separation part provided in the flow path, and separating a specific substance in the sample, and a separation part provided in the separation part A protruding portion, wherein a layer of the substance to be adsorbed that is selectively adsorbed or bonded to the specific substance is formed on the separation section.
- the separation device since the projection is formed on the separation part, the number of molecules of the specific substance that can approach and interact with the substance to be adsorbed on the surface of the separation part can be increased. Adjust the shape and arrangement of the protrusions Thereby, the width of the sample passage path in the separation unit can be adjusted. Therefore, since the shape of the separation section can be optimized according to the molecular size of the specific substance, the separation efficiency can be improved as compared with the conventional method in which the carrier particles are filled in the channel.
- an electrode may be provided in the separation unit and the flow path, and a voltage applying unit that applies a voltage between the electrodes may be further provided.
- a configuration may be adopted in which a projection is provided on the separation section, and an electrode is formed on the projection. This makes it possible to more efficiently guide the charged specific substance to the separation unit. Also, when desorbing a specific substance that is selectively adsorbed or bound to the substance to be adsorbed in the separation unit, desorption becomes easier if the polarity of the potential applied to the electrode is controlled, so desorption flowing in the flow path It is possible to reduce the salt concentration and the organic solvent concentration of the solution for use. Therefore, even when the specific substance is a protein or the like, inactivation / denaturation can be suppressed.
- the combination of the specific substance and the substance to be adsorbed may be an antigen and an antibody, an enzyme and a substrate, an enzyme and a substrate derivative, an enzyme and an inhibitor, a sugar and a lectin, a DNA and a DNA, a DNA and a DNA. It can be any combination of RNA, protein and nucleic acid, metal and protein, or ligand and receptor.
- the separation device according to the present invention has a configuration in which the flow path is formed in the base material, and is a configuration suitable for separating a small amount of sample, so that the separation can be reliably performed.
- the substance to be adsorbed may be provided on a surface of the substrate via a spacer.
- a spacer By providing the spacer, a suitable space is formed between the substance to be adsorbed and the substrate, so that the specific substance can be efficiently adsorbed or bound.
- the spacer by making the spacer a hydrophilic molecule, the surface of the separation part is covered with a hydrophilic graft chain. Therefore, nonspecific adsorption of unnecessary components other than the specific substance to the surface of the separation section can be suppressed.
- a separation comprising: a flow path provided in a base material; a separation section provided in the flow path; and a fine flow path provided in the separation section and narrower than the flow path.
- a liquid containing the substance to be adsorbed is introduced into the flow path while a voltage having a sign different from that of the substance to be adsorbed to be selectively adsorbed or bound to the substance to be separated is applied to the separation part of the device, and the liquid is adsorbed to the separation part Introducing a sample containing the substance to be separated into the flow path, and selectively adsorbing or binding to the substance to be adsorbed; and removing the substance to be separated from the substance to be adsorbed to the flow path. Introducing a desorbing liquid to be separated, desorbing and collecting the substance to be separated, and performing the following steps.
- a separation section of a separation device including: a flow path provided in the base material; a separation section provided in the flow path; and a projection provided in the separation section; Introducing a liquid containing the substance to be adsorbed into the flow path while applying a voltage having a sign different from that of the substance to be adsorbed to be selectively adsorbed or bound to the substance to be separated, and adsorbing the liquid to the separation section; Introducing a sample containing the substance to be separated into the flow path, and selectively adsorbing or binding to the substance to be adsorbed; and a desorbing liquid for desorbing the substance to be separated from the substance to be adsorbed to the flow path. And a step of desorbing and recovering the substance to be separated and recovering the substance to be separated.
- the substance to be adsorbed is adsorbed by adsorbing the substance to be adsorbed, introducing the sample, and desorbing and collecting the specific substance in the sample while applying a voltage to the separation section.
- the specific substance can be easily and reliably separated without being fixed to the base material using a coupling agent or the like.
- the substance to be adsorbed can be adsorbed to the separation section by applying a positive potential to the separation section.
- a separation means for separating a biological sample according to a molecular size or a property comprising: A pretreatment unit for performing the treatment, a drying unit for drying the pretreated sample, and a mass analysis unit for mass spectrometry of the dried sample, wherein the separation unit includes the separation device.
- the biological sample may be extracted from a living body or may be synthesized.
- a flow path provided in a base material a separation part provided in the flow path, a fine flow path provided in the separation part and having a narrower width than the flow path
- the separation section has a layer of the substance to be adsorbed that selectively adsorbs or binds to the specific substance in the sample, so that the specific substance in the sample can be efficiently separated using specific interaction
- An apparatus or method is implemented.
- a small-sized separation device that efficiently separates and recovers a trace amount of a specific substance is realized.
- a separation device or a separation method is realized in which a specific substance is adsorbed and then desorbed by a simple method to recover the specific substance while maintaining high activity. Further, according to the present invention, a mass spectrometry system applicable to a biological sample is realized.
- FIG. 1 is a top view showing the configuration of the separation device according to the present embodiment.
- FIG. 2 is a diagram showing a configuration of a separation region of the separation device of FIG.
- FIG. 3 is a perspective view showing a configuration of a separation unit of the separation device of FIG.
- FIG. 4 is a diagram for explaining the configuration of the surface of the separation device of FIG.
- FIG. 5 is a diagram for explaining the configuration of the surface of the columnar body of the separation device of FIG.
- FIG. 6 is a diagram showing a configuration of the separation device according to the present embodiment.
- FIG. 7 is a diagram for explaining the configuration of the liquid reservoir of the separation device of FIG.
- FIG. 8 is a view for explaining the configuration of the liquid reservoir of FIG. 7 in the BB ′ direction.
- FIG. 9 is a diagram illustrating a configuration of a separation unit of the separation device according to the present embodiment.
- FIG. 10 is a diagram showing a configuration of a separation unit of the separation device of FIG.
- FIG. 11 is a schematic diagram showing the configuration of the mass spectrometer.
- FIG. 12 is a diagram showing the configuration of the separation device according to the present embodiment.
- FIG. 13 is a diagram showing a configuration of a drying unit of the separation device of FIG.
- FIG. 14 is a process cross-sectional view illustrating a method for manufacturing the separation device according to the present embodiment.
- FIG. 15 is a process cross-sectional view illustrating a method for manufacturing the separation device according to the present embodiment.
- FIG. 17 is a process cross-sectional view illustrating a method for manufacturing the separation device according to the embodiment.
- FIG. 17 is a process cross-sectional view illustrating the method for manufacturing the separation device according to the present embodiment.
- FIG. 19 is a diagram showing another example of the separation device.
- FIG. 20 is an enlarged view of the vicinity of the sample quantification tube of the separation device shown in FIG.
- FIG. 21 is a detailed view of the separation device shown in FIG.
- FIG. 22 is a block diagram of a mass spectrometry system including the separation device of the present embodiment.
- FIG. 1 is a top view of the separation device 100 according to the present embodiment.
- a flow path 103 is provided on the substrate 101, and a separation region 113 including a separation portion 107 is formed in a part of the flow path 103. Further, both ends of the flow path 103 are communicated with the sample introduction part 144 and the liquid reservoir 147, respectively.
- the upper surface of the flow path 103 may be covered with a covering member. By providing the covering member on the upper surface of the channel 103, drying of the sample liquid is suppressed.
- the component in the sample is a substance having a higher-order structure such as a protein
- the component is irreversible at the gas-liquid interface by using a coating member with a hydrophilic surface and sealing the inside of the flow path 103. Denaturation is suppressed.
- FIG. 2 is an enlarged view of the separation region 113 in the separation device 100.
- 2 (a) is a top view
- FIG. 2 (b) is a cross-sectional view taken along the line AA ′ of FIG. 2 (a).
- the columnar bodies 105 are regularly formed at regular intervals in the flow path 103, and the liquid flows through the gap between the columnar bodies 105. Since a substance layer to be adsorbed is formed on the surface of the columnar body 105 as will be described later with reference to FIG. 4, specific components in the sample liquid selectively absorb non-adsorbed substances on the surface of the columnar body 105. It is possible to wear or join.
- FIG. 3 is a perspective view showing the configuration of the substrate 101 in the separation unit 107.
- W indicates the width of the channel 103
- D indicates the depth of the channel 103
- ⁇ indicates the diameter of the column 105
- d indicates the height of the column 105
- p Indicates the average distance between adjacent columnar bodies 105.
- R the diameter of the molecule to be separated
- R and p, D, or d satisfy the following conditions.
- FIG. 4 is a diagram for explaining the configuration of the surface of the substrate 101. As shown in FIG. On the substrate 101, an adsorbed substance layer 109 is formed. That is, the substance to be adsorbed is immobilized on the surface of the substrate 101.
- FIG. 5 is a diagram illustrating a state in which the substance A to be adsorbed is fixed to the substance layer 109 to be adsorbed, taking the surface of the columnar body 105 as an example.
- column 1 On the surface of 05, a low molecular substance is immobilized as the substance A to be adsorbed.
- the sample liquid containing the specific substance A ' is introduced into the columnar body 105, the specific substance A' in the sample liquid is selectively applied to the substance A as shown in Fig. 5 (b). Adsorbs or binds to form a complex.
- the separation apparatus 100 only the specific substance A ′ having a specific interaction with the substance A to be adsorbed is selectively adsorbed on the substance layer 109 to be adsorbed and separated from other components in the sample.
- silicon is used as a material of the substrate 101.
- glass such as quartz or a plastic material may be used.
- the plastic material include silicone resins, thermoplastic resins such as PMMA (polymethyl methacrylate), PET (polyethylene terephthalate), and PC (polycarbonate), and thermosetting resins such as epoxy resins. Since such a material is easily formed, the manufacturing cost of the drying apparatus can be reduced.
- the columnar body 105 can be formed, for example, by etching the substrate 101 into a predetermined pattern shape, but the manufacturing method is not particularly limited. Further, the columnar body 105 in FIG. 2 is a cylinder, but is not limited to a pseudocolumn such as a cylinder and a pseudocolumn, but a cone such as a cone and an elliptical cone; a polygonal column such as a triangular prism and a quadrangular prism; Pillars having; and the like.
- the adsorbed substance A and the specific substance A ′ included in the adsorbed substance layer 109 are selected from a combination that selectively adsorbs or binds. As such a combination. For example,
- DNA deoxyribonucleic acid
- RNA liponucleic acid
- any one is the specific substance and the other is the substance to be adsorbed.
- hormones such as steroids, physiologically active substances such as neurotransmitters, drugs, other blood factors, cell membrane receptors such as insulin receptors, or proteins having an affinity for the above receptors, Glycoproteins, glycolipids, or low molecular substances can be used.
- the antigen may be a low molecular substance such as a so-called hapten or a high molecular substance such as a protein.
- antigens include HCV antigens, tumor markers such as CEA and PSA, human immunodeficiency virus (HIV), abnormal prions, and proteins specific to Alzheimer's disease.
- ConA concanapalin A
- ConA receptor monosaccharide protein for example, a combination of N-acetyl-D_darcosamine and wheat germ lectin, concanapalin A (ConA) and ConA receptor monosaccharide protein can be used.
- a mutated DNA and a DNA complementary to the mutated DNA can be used.
- the material can be selected from, for example, the same materials as the substrate 101.
- the same material as the substrate 101 may be used, or a different material may be used.
- the sample liquid containing the specific substance A ′ is injected into the sample introduction part 144, and is developed in the channel 103 by a capillary effect or press-fitting using a pump.
- the flow rate of the sample liquid is, for example, 1 On 1 Zmin or more and 1001 Zmin or less.
- only the specific substance A ′ having a specific interaction with the substance A to be adsorbed selectively adsorbs to the substance layer 109 to be adsorbed in the separation part 107. .
- the component that has not been adsorbed is led to the liquid reservoir 147 together with the solvent or the liquid that is the dispersion medium.
- a buffer solution or the like for washing the flow channel 103 is flown from the sample introduction part 144 to remove components other than the specific substance A ′ staying in the flow channel 103.
- the specific substance A ′ and the substance A to be adsorbed are adsorbed or bound by the specific interaction, they are not dissociated.
- the specific substance A ′ is desorbed from the substance A to be adsorbed.
- a desorption method for example, a method of introducing a NaCl solution of 0.1 mol / 1 or more and 1 mol / 1 or less from the sample introduction section 144 into the flow path 103 can be used.
- the substance A to be adsorbed and the specific substance A ′ are an antigen and an antibody, they have a specific interaction with the substance A to be adsorbed, and the binding constant for the substance A to be adsorbed is higher than that of the specific substance A ′.
- the desorbed specific substance A ' is led to the liquid reservoir 147 and collected.
- the separation portion 107 is formed in the flow path 103. Therefore, even if the sample is very small, the specific substance A can be introduced by introducing it into the flow path 103. 'Can be separated and recovered. The operation is simpler than affinity chromatography using a column. In addition, since the separation device 100 is a disposable chip, the washing operation of the separation device 100 is unnecessary, and the separation can be performed reliably.
- the flow channel groove 103 and the columnar body 105 on the substrate 101 can be formed by etching the substrate 101 into a predetermined pattern shape. Is not particularly limited.
- FIG. 15, FIG. 16, and FIG. 17 are process cross-sectional views showing one example.
- the center is a top view
- the left and right views are cross-sectional views.
- the columnar body 105 is formed by using an electron beam lithography technique using calixarene as a resist for fine processing.
- An example of the molecular structure of calixarene is shown below.
- Calixarene is used as a resist for electron beam exposure, and can be suitably used as a resist for nanofabrication.
- a silicon substrate whose plane orientation is (100) is used as the substrate 101.
- a silicon oxide film 185 A lane electron beam negative resist 18 3 is formed in this order.
- the thicknesses of the silicon oxide film 185 and the calixarene electron beam negative resist 183 are 40 nm and 55 nm, respectively.
- an area to be the columnar body 105 is exposed using an electron beam (EB).
- EB electron beam
- the development is performed using xylene, and rinsed with isopropyl alcohol.
- the lithographic squalene electron beam negative resist 183 is patterned.
- a positive photoresist 155 is applied to the entire surface (FIG. 15 (c)).
- the film thickness is 1.8; ⁇ m.
- mask exposure is performed so as to expose the region to become the flow path 103, and development is performed (FIG. 16 (a)).
- the silicon oxide film 185 is etched by RIE using a mixed gas of CF 4 and CHF 3 .
- the thickness after etching is 35 nm (Fig. 16 (b)) t
- the resist is removed by organic washing using a mixture of acetone, alcohol and water
- an oxidizing plasma treatment is performed (Fig. 16 (c)).
- the substrate 101 is subjected to ECR etching using HBr gas.
- the thickness of the silicon substrate after the etching is set to 40 nm (Fig. 17 (a)).
- wet etching is performed with hydrofluoric acid in a BHF buffer to remove the silicon oxide film (Fig. 17 (b)).
- the flow path 103 and the columnar body 105 are formed on the substrate 101.
- the surface of the substrate 101 hydrophilic By making the surface of the substrate 101 hydrophilic, the sample liquid is smoothly introduced into the channel 103 and the columnar body 105.
- the introduction of the sample liquid by capillary action is promoted by making the surface of the flow path hydrophilic, thereby improving the separation efficiency. I like it.
- the substrate 101 is placed in a furnace to form a silicon thermal oxide film 187 (FIG. 17 (c)).
- heat treatment conditions are selected so that the thickness of the oxide film is 30 nm.
- electrostatic bonding is performed with the coating 189, sealing is performed, and the separation device is used. It is completed (Fig. 17 (d)).
- a known material suitable for the type of the substrate 101 such as press molding using a mold such as etching or emboss molding, injection molding, or photo-curing, is used. Can be done in a way.
- the surface of the substrate 101 hydrophilic.
- the sample liquid is smoothly introduced into the channel 103 and the columnar body 105.
- introduction of the sample liquid by capillary action is promoted by making the surface of the flow path 103 hydrophilic. It is preferable because the drying efficiency is improved.
- Examples of the surface treatment for imparting hydrophilicity include, for example, cutlets having a hydrophilic group.
- the pulling agent can be applied to the side wall of the channel 103.
- Examples of the coupling agent having a hydrophilic group include a silane coupling agent having an amino group.
- These force coupling agents can be applied by a spin coating method, a spray method, a dip method, a gas phase method or the like.
- an adhesion preventing treatment can be performed on the flow path 103.
- the anti-adhesion treatment for example, a substance having a structure similar to the phospholipid constituting the cell wall can be applied to the side wall of the flow path 103.
- the c hydrophilic treatment and adhesion preventing process can be improved, for example, can be used Ripijiyua (registered trademark, manufactured by NOF Corporation).
- Lipidure (registered trademark) is dissolved in a buffer solution such as a buffer so as to have a concentration of 0.5 wt%, and the solution is filled in the flow channel 103 and left for several minutes to flow.
- the inner wall of road 10'3 can be treated. Thereafter, the solution is blown off with an air gun or the like to dry the channel 103.
- a fluororesin can be applied to the side wall of the channel 103.
- a method for immobilizing the substance to be adsorbed on the surface of the substrate 101 in the separation unit 107 for example, a method such as a physical adsorption method or a covalent bonding method can be used.
- a monomolecular film of the substance to be adsorbed can be prepared and adsorbed on the surface of the substrate 101 in the separation section 107.
- the surface of the substrate 101 is subjected to surface
- the substrate 101 is brought into contact with the solution containing the substance to be adsorbed by introducing a functional group or an active group of the above, so that the substance to be adsorbed can be bonded to the surface of the substrate 101.
- the method for modifying the surface of the substrate 101 can be appropriately selected according to the purpose. For example, a plasma treatment, a treatment with an ion beam, an electron beam treatment, or the like can be used.
- a spacer molecule can be immobilized on the surface of the substrate 101, and the spacer molecule can be bound to the substance to be adsorbed. The method of immobilizing the spacer molecule will be described later.
- a coupling agent such as a silane coupling agent can be used to chemically bond the substance A to be adsorbed to the surface.
- a coupling agent is used, the coupling agent is applied to the surface of the columnar body 105, and then the organic functional group of the coupling agent is bonded to the substance A to be adsorbed.
- a thiol group, an amino group, a propyloxyl group, an aldehyde group, a hydroxyl group, or the like of the substance A to be adsorbed can be used.
- the substrate 101 of the ligand can be immobilized as follows.
- the substrate 101 is immersed in an aqueous solution of a silane coupling agent having an —NH 2 group.
- concentration of the silane coupling agent is, for example, 0.1% or more and 2.0% or less.
- the ligand is immobilized on the substrate 101 surface-treated with the silane coupling agent by a method using a condensing reagent such as, for example, a carbodiimide method. In the case of immobilization, an activator such as N-hydroxysuccinimide may be used if necessary.
- One NH 2 group of the silane coupling agent binds to the carboxyl group of the ligand. In this way, a separation unit 107 is obtained in which the layer on which the ligand is immobilized is used as the substance layer 109 to be adsorbed.
- the substance A to be adsorbed is previously biotinylated. If it is biotinylated, avidin or streptavidin can be immobilized on the substrate 101, and the specific substance can be selectively adsorbed by the interaction between biotin and avidin. At this time, since the binding constant between avidin and biotin is significantly larger than the binding constant between normal antigen and antibody, The specific substance A ′ can be desorbed from the adsorbed substance A and recovered under the condition that the adsorbed substance A does not desorb from the avidin or the like immobilized on the substrate 101.
- the fixed density of the substance to be adsorbed on the substrate 101 is preferably sufficiently dense so that the specific substance can bind to the substance to be adsorbed. By doing so, non-specific adsorption or binding of other substances contained in the sample to the substrate 101 surface can be suppressed.
- the substance A to be adsorbed is a low molecular substance and the specific substance A 'is a high molecular substance with a raised structure, the specific substance A' cannot be adsorbed or bound to the substance A due to steric hindrance. It is preferable to set the fixed density so as not to cause any problem.
- a ⁇ -type polymer layer to which a specific substance can be bonded is provided on the surface of the substrate 101 by using a molecular imprinting method.
- the molecular imprinting method is a method of synthesizing a polymer material that recognizes the target molecule in a tailor-made manner in one step according to the target molecule, and is specifically performed as follows. First, the target molecule is made into a ⁇ type, and a functional monomer is bound by a covalent bond or a non-covalent bond to form a ⁇ type molecule-functional polymer complex.
- the functional monomer a difunctional or higher functional monomer having a functional group capable of binding to the ⁇ -type molecule and a polymerizable group such as a vinyl group can be used.
- a crosslinking agent and a polymerization initiator are added to the solution containing the ⁇ -type molecule-monofunctional monomer complex, and a polymerization reaction is performed on the wall surface of the separation unit 107.
- the type I molecule is decomposed and removed from the polymerized polymer by, for example, enzymatic decomposition. Then, a specific binding site for the type I molecule is formed in the obtained polymer.
- a spacer 11 9 is appropriately placed between the substrate 101 and the substance A to be adsorbed.
- the spacer 1 19 is to separate the substance A from the substrate 101 so that the selective adsorption or binding of the specific substance A ′ and the substance A can proceed without steric hindrance. Therefore, it refers to a compound that is inserted between the substrate 101 and the substance A to be adsorbed.
- the spacer 119 preferably has a relatively short chain length. Further, those having an active group are preferred. This is because the operation of immobilizing the substance A to be adsorbed becomes easier.
- the active group is not particularly limited as long as it is a functional group having reactivity with the substance A to be adsorbed. If the spacer 119 does not have an active group, the functional group of the spacer 119 and the substance A to be adsorbed are bonded using a condensing reagent or the like. For example, a thiol group, an amino group, a propyloxyl group, an aldehyde group, a hydroxyl group, etc. of the substance A to be adsorbed can be used.
- HMDA hexamethylenediamine
- EGDG ethylene glycol diglycidyl ether
- PEG Short chain polyethylene glycol
- PEO polyethylene oxide
- a structure in which the substance A to be adsorbed is fixed on the surface of the substrate 101 a structure in which a ⁇ -type polymer layer to which the specific substance A ′ can be bound by a molecular printing method may be provided. .
- FIG. 9 is a diagram showing a configuration of the separation region 113 of the separation device 100 according to the present embodiment.
- 9 (a) is a top view
- FIG. 9 (b) is a cross-sectional view taken along the line CC ′ of FIG. 9 (a).
- the partition walls 151 are formed regularly at regular intervals in the flow path 103, and the liquid flows through the gap between the partition walls 151. That is, channels narrower than channel 103 are formed, and these fine channels are used as channels 149 for separation.
- the surface of the separation channel 149 is the same as the first embodiment. Similarly, since the substance layer 109 to be adsorbed is formed, the specific substance A 'in the sample liquid can be selectively adsorbed or bound to the non-adsorbed substance A in the separation channel 149. It is.
- the separation region 113 in FIG. 9 can be manufactured in the same manner as in the first embodiment.
- FIG. 14 is a process cross-sectional view illustrating the method for manufacturing the separation device according to the present embodiment.
- a mold 173 including an electrode mounting portion is prepared (FIG. 14 (a)).
- the electrode 1775 is set on the mold 173 (FIG. 14 (b)).
- the material used for the electrode 175 is, for example, Au, P 1;, Ag, A 1, Cu, or the like.
- the coating mold 1779 is set on the mold 1703, the electrode 1775 is fixed, and the resin 1177 which will become the substrate 101 is injected into the mold 1733. And molding (Fig. 14 (c)).
- PMMA is used as the resin 177.
- the substrate 101 having the flow path 103 formed thereon is obtained (FIG. 14D).
- Impurities on the surface of the electrode 175 on the back surface of the substrate 101 are removed by asking to expose the electrode 175 material metal.
- a metal film is formed on the bottom surface of the substrate 101 by vapor deposition or the like, and this is used as a wiring 181 (FIG. 14 (e)).
- the separation portion 107 having the electrode 175 as the columnar body 105 is formed in the channel 103.
- the electrode or wiring 18 1 thus formed is connected to an external power supply (not shown) so that a voltage can be applied.
- an insulating film may be formed on the entire surface of the channel 103. At this time, the thickness of the insulating film is, for example, 10 nm or more and 500 nm or less.
- the sample introduction part If electrodes are formed in the same manner or in the method described in the fourth embodiment, the electrodes are connected to an external power supply (not shown) by conducting the electrodes on the lower surface of the substrate 101 or the like. , Between the sample introduction part 145 and the separation part 107, between the separation part 107 and the liquid reservoir 147, and between the sample introduction part 145 and the liquid reservoir 147. Each of these voltages can be applied.
- the target component in the sample can be more reliably and efficiently separated.
- the sample introduction part 144 is a positive electrode, and the separation part is When a current is passed through the negative electrode 107, the positively charged protein is efficiently guided to the separating portion 107, and is selectively adsorbed to the substance layer 109 to be adsorbed.
- the separation section 107 was turned on as the positive electrode and the reservoir 147 was turned on as the negative electrode, it was retained in the substance layer 109 to be adsorbed. Protein desorption and induction into the reservoir 147 are promoted.
- the application of an AC electric field increases the motility of the protein molecules and further promotes desorption.
- the salt concentration and the organic solvent concentration of the eluent flowing through the flow path 103 for desorbing the specific substance A ′ and the substance A to be adsorbed can be reduced. Therefore, even when the specific substance A ′ is a substance having a higher-order structure such as a protein, irreversible denaturation and inactivation of the three-dimensional structure can be suppressed.
- the operation of immobilizing the substance A to be adsorbed on the substrate 101 may not be required in some cases.
- the substance A to be adsorbed is a protein
- the receptor for the substance is a specific substance A '
- the ligand is not charged or positively charged under the pH condition where the protein is negatively charged
- the specific substance A ′ can be separated as follows.
- a solution of the substance A to be adsorbed that is, a protein
- the column To apply an electrostatic field.
- the protein is adsorbed on the surface of the pillar 105 by electrostatic interaction.
- a sample containing a ligand is introduced into the channel 103.
- the ligand is adsorbed on the protein surface, it is separated from other components.
- the ligand is desorbed from the protein and collected by flowing a salt solution or the like after washing the channel 103.
- the state in which the protein is adsorbed on the surface of the columnar body 105 is maintained.
- FIG. 6 is a diagram showing a configuration of the separation device 171 according to the present embodiment.
- a separation channel 1311 is formed on the substrate 121, and an input channel 1229 and a collection channel 1335 are formed so as to intersect with this.
- C The input channel 1 2 9, the separation channel 1 3 1, and the recovery channel 1 3 5 have liquid reservoirs at both ends 1 2 5 a, 1 2 5 b and 1 2 3, respectively.
- a, 123 b, 127 a and 127 b are formed.
- Each of the liquid reservoirs is provided with an electrode, which can be used to apply a voltage to both ends of the separation channel 131, for example.
- a separation section 107 is provided in the separation flow path 13 1.
- the configuration of the separation unit 107 may be the configuration described in any of the first to third embodiments.
- FIG. 7 is an enlarged view of the vicinity of the liquid reservoir 123 in FIG.
- FIG. 8 is a sectional view taken along the line BB ′ of FIG. Separation channels 1 3 1 and
- a cover 133 provided with an opening 133 for injecting a buffer solution or the like is provided on the substrate 121 provided with the liquid reservoir 123a.
- a conductive path 141 is provided on the cover 137 so that it can be connected to an external power supply.
- the electrode plate 144 is disposed along the wall surface of the liquid reservoir 123 a and the conductive path 141.
- Electrode plate 144 and conductive path 144 are crimped and electrically connected.
- the other reservoirs have the same structure as above.
- the electrode plates 144 formed in the respective reservoirs are connected to an external power supply (not shown) by conducting the lower surface of the substrate 101 and the like, a voltage can be applied.
- a sample containing the specific substance A ' is injected into the reservoir 125a or the reservoir 125b.
- a voltage is applied so that the sample flows in the direction of the reservoir 125b, and when the liquid is poured into the reservoir 125b, the reservoir 1
- the separation device 17 1 has a charging channel 1 29 and a collecting channel 1 35 in addition to the separation channel 13 1, so that unnecessary components and the specific substance A 'are stored in different reservoirs. Can lead. For this reason, mixing of unnecessary components remaining in the liquid reservoir into the specific substance A ′ is suppressed, and the separation efficiency is further improved.
- a reaction reagent into the liquid reservoir 125a or liquid reservoir 125b, a specific substance A 'induced in the recovery channel 135 can be used for enzyme reaction and detection. It is possible to carry out various reactions such as a color reaction.
- FIG. 12 is a diagram showing the configuration of the separation device 165 according to the present embodiment.
- the separation device 165 has the basic configuration of the separation device 100 described in the third embodiment.
- the substrate 101 in the separation device 100 corresponds to the substrate 133 in the separation device 165, and the channel 103 corresponds to the first channel 157, respectively.
- the second flow path 159 which is narrower than the first flow path 157, communicates with the flow path 157.
- a drying section 161 is provided at the end of the second flow path 159.
- Coatings 163 are provided on the upper surfaces of the first channel 157 and the second channel 159, and the sample introduction section 145, the liquid reservoir 147, and the drying section 161 are provided.
- the upper surface is an opening.
- a metal film (not shown) is provided on the surfaces of the sample introduction part 145, the liquid reservoir 147, the first flow path 157, and the drying part 161. Voltage can be applied between them.
- FIG. 13 is a diagram showing the configuration of the drying unit 161 in the separation device 165.
- Fig. 13 (a) is a top view
- Fig. 13 (b) is a cross-sectional view taken along the line D-D 'in Fig. 13 (a).
- the drying section 161 is provided with a plurality of columnar bodies 167.
- a heater 169 is provided on the bottom of the drying unit 161 to promote drying.
- the method of using the separator 165 is as follows. That is, first, the sample liquid containing the specific substance A ′ is injected from the sample introduction part 145, and is developed in the first channel 157 by a capillary effect or press-fitting using a pump.
- the sample introduction part 145 is used as a positive electrode and the separation part 107 is used as a negative electrode, because the induction of the specific substance A ′ to the separation part 107 is promoted.
- the components not adsorbed on the substance A to be adsorbed are guided to the liquid reservoir 147 together with the solvent or the liquid as the dispersion medium, and are discharged.
- a buffer solution for washing the flow path 103 is passed through the sample introduction part 145 to wash, and components other than the specific substance A ′ staying in the first flow path 157 are removed.
- the specific substance A ′ and the substance A to be adsorbed are adsorbed or bound by the specific interaction, they are not dissociated.
- the specific substance A ′ is desorbed from the substance A to be adsorbed in the same manner as in the first and second embodiments.
- power is supplied to the separation unit 107 as the positive electrode and the drying unit 161 to the negative electrode, and when the drying unit 161 is heated to, for example, 30 ° C or more and 70 ° C or less by the heater 169, the dissociation is identified.
- the liquid containing the substance A ' is led to the drying section 161 via the second flow path 159, and is dried quickly in the drying section 161.
- a plurality of columnar bodies 167 are provided in the drying section 161, and the liquid in the second flow path 159 is efficiently introduced by capillary action, and drying proceeds promptly.
- the second flow path 159 is narrower than the first flow path 157, the first flow path 157 is efficiently moved from the first flow path 157 to the second flow path 159. Liquid is introduced.
- the specific substance A 'separated in the separation unit 107 is dried in the drying unit 161 and collected.
- FIG. 11 is a schematic diagram showing the configuration of the mass spectrometer.
- a dried sample is placed on a sample stage. Then, the dried sample is irradiated with a nitrogen gas laser having a wavelength of 337 nm under vacuum. The dried sample then evaporates with the matrix.
- the sample stage is an electrode, and when a voltage is applied, the vaporized sample flies in a vacuum and is detected by a detection unit that includes a reflector detector, a reflector, and a linear detector.
- the separation device 165 only the specific substance A ′ can be separated from a sample containing a plurality of components, and further dried and collected. Then, the dried specific substance A ′ can be subjected to MALD I — TO F MS together with the separation device 165. Therefore, the extraction, drying, and structural analysis of the target component can be performed on a single separation device 165, which is useful for proteome analysis and the like.
- the matrix for MALD I-TOFMS is appropriately selected depending on the substance to be measured.
- ⁇ -CHCA cyano 4-hydroxycinnamic acid
- 2,5-DHB 2,5- Dihydroxybenzoic acid
- DHBs 5-methoxysalicylic acid
- HABA 4- (4-hydroxyphenylazo) benzoic acid
- Disulanol THAP
- a GFP Green Fluorescent
- His-Tag an anti-His-Tag (histidine tag) antibody
- Protein purification method
- the anti-His-Tag antibody is immobilized on the surface of the separation portion 107 to form the adsorbed substance layer 109.
- immobilization for example, the same method as in the first embodiment or a known method for immobilizing an antibody for affinity chromatography is used.
- the separation unit 107 is subjected to a surface treatment using a silane coupling agent having one NH 2 group.
- a spacer is coupled to the separation unit 107.
- EGD E ethylene glycol diglycidyl ether
- a large excess of EGDE is added to a pH II NaOH solution and the mixture is stirred at 30 ° C., for example. This solution is added dropwise to the separation unit 107 and reacted for, for example, 24 hours.
- the anti-His-Tag antibody is immobilized using the epoxy group at the end of the spacer.
- the extract containing His-Tag-added GFP expressed in Escherichia coli is introduced into the sample introduction part 145 of the obtained separator 100. Then, only the GFP to which the His-Tag is added selectively interacts with the anti-His-Tag antibody and is adsorbed on the substance layer 109 to be adsorbed. When the separation part 107 is observed after washing the flow path 103, the region where GFP is adsorbed emits green fluorescence, so that it can be easily confirmed visually.
- the His-Tag-added GFP can be obtained from the liquid reservoir 147. Can be recovered.
- an anti-His-Tag antibody was used. You may. Further, the purification method of the present embodiment is also applicable to the configuration of the separation device described in the second to fifth embodiments.
- This embodiment relates to a method for separating a substance having a specific interaction with a metal using the separation device 100 according to the first embodiment.
- Such a separation device is manufactured as follows. That is, following the step of FIG. 17 (c), a resist film is provided on the entire surface of the substrate 101, and a resist pattern exposing only the region to be the separation portion 107 is formed. This resist pattern
- a metal film is formed on the entire surface of the substrate using the mask as a mask.
- the material of the metal film is a substance that is stable in water, such as Pt and Au.
- the metal film is formed by, for example, vapor deposition. Then, if the resist is removed using a stripper that dissolves the resist mask without dissolving the silicon thermal oxide film 187, a metal film is formed on the surface of the separation portion 107.
- the metal binding substance By introducing a sample containing a metal binding substance into the obtained separation device 100, the metal binding substance can be efficiently separated.
- An embodiment may be used in which a chelating agent, a chelating protein, or a crown ether that chelate ions is used and immobilized on the surface of the separation unit 107 in a state where these are chelated.
- the immobilization at this time can be performed in the same manner as in the first embodiment.
- the separation method of the present embodiment is also applicable to the configuration of the separation device described in the second to fifth embodiments.
- the separation apparatus 100 uses lectin as the substance A to be adsorbed and uses lectin as a lectin relating to a method for separating a specific sugar chain in a sample.
- Concanapalin A is used.
- Recti Is a lectin specific to mannose and glucose in monosaccharides, and has affinity for glycoproteins having high mannose-type sugar chains and polysaccharides.
- ConA is immobilized on the surface of the separation section 107 to form an adsorbed substance layer 109.
- the separation unit 107 is subjected to a surface treatment using a silane coupling agent having an —NH 2 group.
- a spacer is coupled to the separation unit 107.
- EGD E ethylene glycol diglycidyl ether
- a large excess of EGDE is added to a pH II NaOH solution and stirred at, for example, 30 ° C. This solution is added dropwise to the separation unit 107 and reacted for, for example, 24 hours.
- the lectin is immobilized using the epoxy group at the end of the spacer.
- an alkaline solution of lectin containing —SH group, —OH group, and —NH 2 is dropped into the separation unit 107 provided with the spacer.
- the separation apparatus 100 By using the obtained separation apparatus 100, the presence or absence of a glycoprotein or polysaccharide having a high-mannose type sugar chain can be easily separated with high precision and high sensitivity, and recovered.
- a spacer is provided between the lectin and the surface of the substrate 101, thereby facilitating the specific interaction between the lectin and the sugar chain. . Therefore, separation can be performed more efficiently.
- the separation method of the present embodiment is also applicable to the configuration of the separation device described in the second to fifth embodiments.
- FIG. 18 is a diagram showing a configuration of a separation apparatus that moves a sample by utilizing a capillary phenomenon. By utilizing the capillary phenomenon, it is not necessary to apply external force such as electric power and pressure, and energy for driving is unnecessary.
- the separation section (not shown) described in the first embodiment is formed in the separation channel 540 provided in the substrate 550.
- An air hole 560 is provided at one end of the separation channel 540, and a buffer inlet 510 for injecting a buffer at the time of separation is provided at the other end.
- the separation channel 540 is hermetically closed except for the buffer inlet 510 and the air hole 560.
- a sample quantification tube 530 is connected to the starting portion of the separation channel 540, and a sample injection port 520 is provided at the other end of the sample quantification tube 530.
- FIG. 20 is an enlarged view showing the vicinity of the sample quantification tube 5330.
- a hydrophilic absorption region is provided inside the sample quantitative tube 530, the sample holding section 503, and the buffer introduction section 504.
- An absorption region 506 is also provided near the inlet to the separation channel 540.
- a temporary stop slit 502 is provided between the sample quantitative tube 530 and the sample holding section 503.
- the pause slit 502 can be a hydrophobic region.
- the absorption zones are separated by pause slits 505 and 507.
- the void volume of the sample holder 503 is substantially equal to the sum of the void volume of the sample quantitative tube 5330 and the volume of the temporary stop slit 502.
- the width of the pause slit 505 is smaller than the width of the pause slit 502.
- the sample quantification tube 530 has a hydrophilic function, and is configured to function as a sample introduction unit.
- the sample is gradually injected into the sample injection port 5200 to fill the sample quantitative tube 5330. At this time, make sure that the water surface does not rise.
- the sample metering tube 530 is filled with sample, the sample gradually seeps into the pause slit 502.
- the sample inside the pause slit 502 and the sample quantification tube 530 becomes a sample with a larger capillary effect. Holder It is all sucked up to 503.
- each absorption region is formed so as to have a different degree of hydrophilicity depending on the selection of the hydrophilic material, and the sample holding section 503 has a larger capillary effect than the sample quantitative tube 530.
- the pause slits 505 and 507 exist, so that the sample does not flow into the buffer introducing section 504.
- a separation buffer is injected into the buffer inlet 510.
- the injected buffer is temporarily filled in the buffer introduction section 504, and the interface with the sample holding section 503 becomes linear.
- the buffer is further filled, it is exuded into the pause slit 505, flows into the sample holding section 503, and further passes through the pause slit 507 while dragging the sample for separation. It proceeds in the direction of the flow path.
- the width of the pause slit 502 is larger than the width of the pause slits 505 and 507, even if the buffer flows backward to the pause slit 502, the sample is already sampled. There is almost no backflow of the sample because it is proceeding before the holding section 503.
- the separation buffer 1 is a capillary phenomenon, and the separation flow path is further advanced toward the air hole 560. In this process, the sample is separated. When the separation buffer reaches the air hole 560, the buffer flow stops. Measure the separation of the sample when the buffer flow is stopped or when the buffer is in progress.
- the above embodiment is an example of a separation apparatus using the capillary phenomenon. Another example of sample injection utilizing this principle will be described with reference to FIGS. 19 and 21 .
- a sample introduction tube 570 is provided in place of the sample quantification tube 530 in 8.
- a sample inlet 520 and an outlet 580 are provided.
- the sample is introduced into the sample inlet 520 and filled up to the outlet 580. During this time, the sample is absorbed by the sample holder 503 through the charging hole 509. Thereafter, air is injected into the sample inlet 520, and the sample is discharged from the outlet 580, thereby wiping and drying the sample inside the sample inlet tube 570.
- a separation buffer is injected as described above.
- electrophoretic separation a buffer for electrophoresis is introduced from the liquid reservoir corresponding to the buffer inlet 510 and the liquid reservoir corresponding to the air hole 560 before the sample is introduced. Due to the presence of the widely formed pause slits 505 and 507, they do not flow into the sample holder.
- the electrophoresis buffer 1 is made continuous, and a voltage is applied for separation.
- FIG. 22 is a block diagram of a mass spectrometry system including the separation device of the present embodiment. As shown in Fig. 22 (a), this system provides purification 1002 of sample 1001 to remove some contaminants and separation 1000 to remove unnecessary components 1004. 3. It has means for executing the steps of pretreatment of the separated sample (105), drying of the sample after the pretreatment (106), and identification (107) of the sample by mass spectrometry.
- the separation by the separation device described in the above embodiment corresponds to the step of separation 1003, and is performed on the microchip 1008.
- a separation device for removing only macro components such as blood cells is used.
- the pre-processing step 105 the molecular weight is reduced using trypsin or the like, mixed with a matrix, or the like.
- drying 106 the pretreated sample is dried to obtain a dry sample for mass spectrometry.
- the separation device according to the present embodiment has a flow path, as shown in FIG. 22 (b), the steps from purification 102 to drying 106 are performed on one microchip. It can also be performed on 1 0 8.
- the steps from purification 102 to drying 106 are performed on one microchip. It can also be performed on 1 0 8.
- By continuously processing the sample on the microchip 108 it is possible to efficiently and reliably identify even a very small amount of a component using a method with little loss.
- appropriately selected steps or all steps can be performed on the microchip 1008.
- the reaction apparatus 100 in which the columnar body 105 is formed on the surface of the channel 103 by the method described in the first embodiment is manufactured.
- the substrate 101 is formed of a silicon substrate having a (100) plane as a main surface.
- a column 105 (FIG. 2) is provided in the separating part 107.
- the columnar body 105 is formed by the method described with reference to FIGS.
- the interval p between the pillars 105 is set to about 200 nm.
- the antisense oligonucleotide A against a part of the tpa_1 gene of the nematode (C. elegans: Caenorhabditise 1 egans) was coated on the surface of the silicon pillar, which is the pillar 105, using a coupling agent. Fix to the pillar surface.
- the 5 ′ end of the antisense oligonucleotide A is modified with an SH group.
- N- (2-aminoethyl) —3-aminopropyl N- (2-aminoethyl) —3-aminopropyl, a kind of aminosilane, is used.
- EDA trimethoxysilane
- the separation unit 1 0 7 1 1 conc. HC 1: to immersion CH 3 ⁇ _H about 30 minutes, washed with distilled water and immersed in concentrated H 2 S_ ⁇ 4 for about 30 minutes. After washing with distilled water, boil for several minutes in deionized water. Subsequently, aminosilane, such as 1% EDA (in an aqueous solution of ImM acetic acid), is introduced into the separation unit 107, and the mixture is allowed to reach room temperature Incubate for about 20 minutes. As a result, the EDA is fixed to the surface of the separation unit 107. Then, the residue is washed with distilled water and dried by heating at about 120 ° C for 3 to 4 minutes in an inert gas atmosphere.
- aminosilane such as 1% EDA (in an aqueous solution of ImM acetic acid)
- succinimidyl 4- (maleimidophenyl) butylate (SMPB) in ImM dissolve in a small amount of DMS O, and dilute.
- the separating part 107 is immersed in this diluted solution at room temperature for 2 hours, washed with a diluting solvent, and dried under an inert gas atmosphere.
- the ester group of SMPB reacts with the amino group of EDA, and the maleimide is exposed on the surface of the separating portion 107.
- the antisense oligonucleotide A having a thiol group is introduced into the separation part 107.
- the thiol group of the antisense oligonucleotide A reacts with the maleimide on the surface of the separation part 107, and the antisense oligonucleotide A is fixed on the surface of the separation part 107 (for example, Chrisey et al., Nu. cleic Acids Research, 1996, Vol. 24, No. 15, 30, 31 to 30-39).
- RNA extracted from C. elegans is mixed with a hybridization solution (Rapidhybridizitationbuffer, manufactured by Amérsham).
- a sample was introduced from the sample introduction part 1 45, and after reacting at 70 ° C for 2 hours in a humidity chamber, 2 XSSC (standard saline citrate buffer) and 0.1% SDS (do Wash with sodium xyl sulfate) at room temperature for 15 minutes, then with 0.2 X SSC, 0.1% SDS for 65 t for 15 minutes.
- DEPC diethylprocarbonate
- DEPC diethylprocarbonate
- RNA having a specific sequence can be satisfactorily separated from the RNA mixture.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Manufacturing & Machinery (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004556860A JPWO2004051231A1 (ja) | 2002-11-29 | 2003-11-28 | 分離装置および分離方法 |
US10/536,798 US20060000772A1 (en) | 2002-11-29 | 2003-11-28 | Separation apparatus and separation method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002349301 | 2002-11-29 | ||
JP2002-349301 | 2002-11-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004051231A1 true WO2004051231A1 (ja) | 2004-06-17 |
Family
ID=32463030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/015260 WO2004051231A1 (ja) | 2002-11-29 | 2003-11-28 | 分離装置および分離方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20060000772A1 (ja) |
JP (1) | JPWO2004051231A1 (ja) |
CN (1) | CN1720438A (ja) |
WO (1) | WO2004051231A1 (ja) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005257544A (ja) * | 2004-03-12 | 2005-09-22 | Gl Sciences Inc | マイクロチップ |
US20060160243A1 (en) | 2005-01-18 | 2006-07-20 | Biocept, Inc. | Recovery of rare cells using a microchannel apparatus with patterned posts |
WO2006098502A1 (en) * | 2005-03-18 | 2006-09-21 | Canon Kabushiki Kaisha | Pillar structure for separating or capturing target substance |
JP2006296427A (ja) * | 2005-04-15 | 2006-11-02 | Samsung Electronics Co Ltd | 疎水性固体支持体を利用した細胞分離方法 |
EP1815244A1 (en) * | 2004-11-11 | 2007-08-08 | Agency for Science, Technology and Research | Cell culture device |
WO2007135826A1 (ja) * | 2006-05-23 | 2007-11-29 | The University Of Electro-Communications | 目的物質の塗布方法、及びマイクロ化学チップ |
WO2008020593A1 (fr) * | 2006-08-14 | 2008-02-21 | Tokyo Electron Limited | colonne pour chromatographie et son procédé de fabrication |
JP2008048735A (ja) * | 2006-08-21 | 2008-03-06 | Samsung Electronics Co Ltd | 非平面状の固体支持体を用いた微生物の分離方法及び分離装置 |
JP2008249538A (ja) * | 2007-03-30 | 2008-10-16 | Seiko Epson Corp | 検出素子 |
WO2008011486A3 (en) * | 2006-07-19 | 2008-10-23 | Biocept Inc | Detection or isolation of target molecules using a microchannel apparatus |
JP2010078482A (ja) * | 2008-09-26 | 2010-04-08 | Fujifilm Corp | 質量分析用基板および質量分析方法 |
US7695956B2 (en) | 2006-01-12 | 2010-04-13 | Biocept, Inc. | Device for cell separation and analysis and method of using |
US7811829B2 (en) * | 2006-06-08 | 2010-10-12 | Canon Kabushiki Kaisha | Measuring probe and production process thereof |
JP2010236945A (ja) * | 2009-03-30 | 2010-10-21 | Sharp Corp | 被検体物質の固定化方法およびマイクロ分析装置 |
JP2011500018A (ja) * | 2007-10-11 | 2011-01-06 | エージェンシー フォー サイエンス, テクノロジー アンド リサーチ | ケージ中で一時的リンカーを用いて細胞構造体を形成する方法 |
JP2011520117A (ja) * | 2008-05-06 | 2011-07-14 | コミサリア ア レネルジー アトミック エ オ ゼネルジー アルテルナティブ | 流体から生体分子を分離する装置 |
WO2011104990A1 (ja) * | 2010-02-25 | 2011-09-01 | 東京エレクトロン株式会社 | クロマトグラフィー用カラム、その製造方法、および分析装置 |
JP2011220768A (ja) * | 2010-04-07 | 2011-11-04 | Sharp Corp | 分析装置および分析方法 |
US8158411B2 (en) | 2006-08-21 | 2012-04-17 | Samsung Electronics Co., Ltd. | Method of separating microorganism using nonplanar solid substrate and device for separating microorganism using the same |
JP2015099031A (ja) * | 2013-11-18 | 2015-05-28 | 株式会社東芝 | 半導体マイクロ分析チップ及びその製造方法 |
US9212977B2 (en) | 2005-01-18 | 2015-12-15 | Biocept, Inc. | Cell separation using microchannel having patterned posts |
US10369568B2 (en) | 2005-01-18 | 2019-08-06 | Biocept, Inc. | Cell separation using microchannel having patterned posts |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8895298B2 (en) | 2002-09-27 | 2014-11-25 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
CA2529285A1 (en) * | 2003-06-13 | 2004-12-29 | The General Hospital Corporation | Microfluidic systems for size based removal of red blood cells and platelets from blood |
WO2006075966A1 (en) * | 2005-01-17 | 2006-07-20 | Gyros Patent Ab | A versatile flow path |
US20060121624A1 (en) * | 2004-03-03 | 2006-06-08 | Huang Lotien R | Methods and systems for fluid delivery |
US20050282293A1 (en) * | 2004-03-03 | 2005-12-22 | Cosman Maury D | System for delivering a diluted solution |
US20050242017A1 (en) * | 2004-04-15 | 2005-11-03 | Staats Sau Lan T | Microfluidic devices for liquid chromatography and mass spectrometry |
EP1901067A3 (en) * | 2004-08-03 | 2009-05-13 | On-Chip Cellomics Consortium | Cellomics system |
US8053214B2 (en) * | 2004-09-09 | 2011-11-08 | Microfluidic Systems, Inc. | Apparatus and method of extracting and optically analyzing an analyte from a fluid-based sample |
US20090111197A1 (en) * | 2005-03-29 | 2009-04-30 | Inverness Medical Switzerland Gmbh | Hybrid device |
US20070196820A1 (en) | 2005-04-05 | 2007-08-23 | Ravi Kapur | Devices and methods for enrichment and alteration of cells and other particles |
US20060223178A1 (en) * | 2005-04-05 | 2006-10-05 | Tom Barber | Devices and methods for magnetic enrichment of cells and other particles |
US20070026418A1 (en) * | 2005-07-29 | 2007-02-01 | Martin Fuchs | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
EP1915618A4 (en) * | 2005-06-02 | 2009-09-30 | Fluidigm Corp | ANALYSIS USING MICROFLUIDIC SEPARATION DEVICES |
US20090181421A1 (en) * | 2005-07-29 | 2009-07-16 | Ravi Kapur | Diagnosis of fetal abnormalities using nucleated red blood cells |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US20070059719A1 (en) * | 2005-09-15 | 2007-03-15 | Michael Grisham | Business methods for prenatal Diagnosis |
US20070059774A1 (en) * | 2005-09-15 | 2007-03-15 | Michael Grisham | Kits for Prenatal Testing |
US20070059781A1 (en) * | 2005-09-15 | 2007-03-15 | Ravi Kapur | System for size based separation and analysis |
TW200734641A (en) * | 2005-12-26 | 2007-09-16 | Inst Of Microchemical Technology | Microchip for immunoassay, kit for immunoassay and immunoassay method |
US20080050739A1 (en) * | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US8372584B2 (en) * | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
WO2007147074A2 (en) | 2006-06-14 | 2007-12-21 | Living Microsystems, Inc. | Use of highly parallel snp genotyping for fetal diagnosis |
US20080124721A1 (en) * | 2006-06-14 | 2008-05-29 | Martin Fuchs | Analysis of rare cell-enriched samples |
US8137912B2 (en) * | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US8349167B2 (en) | 2006-12-14 | 2013-01-08 | Life Technologies Corporation | Methods and apparatus for detecting molecular interactions using FET arrays |
US8262900B2 (en) | 2006-12-14 | 2012-09-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
EP2677309B9 (en) | 2006-12-14 | 2014-11-19 | Life Technologies Corporation | Methods for sequencing a nucleic acid using large scale FET arrays, configured to measure a limited pH range |
US11339430B2 (en) | 2007-07-10 | 2022-05-24 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
WO2009048642A1 (en) * | 2007-10-11 | 2009-04-16 | Accelbeam Devices Llc | Microwave reactor |
US8974749B2 (en) * | 2008-06-16 | 2015-03-10 | Johnson & Johnson Ab | Assay device and method |
PT2334812T (pt) | 2008-09-20 | 2017-03-29 | Univ Leland Stanford Junior | ¿diagnóstico não invasivo de aneuploidia fetal por sequenciação |
US20100137143A1 (en) | 2008-10-22 | 2010-06-03 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
US20100301398A1 (en) | 2009-05-29 | 2010-12-02 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
WO2010085815A1 (en) * | 2009-01-26 | 2010-07-29 | Artemis Health, Inc. | Methods and compositions for identifying a fetal cell |
CA2756493C (en) | 2009-03-24 | 2019-07-02 | Biocept, Inc. | Devices and methods of cell capture and analysis |
US20120100538A1 (en) | 2009-03-24 | 2012-04-26 | Biocept, Inc. | Devices and methods of cell capture and analysis |
US8776573B2 (en) | 2009-05-29 | 2014-07-15 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
US20120261274A1 (en) | 2009-05-29 | 2012-10-18 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
US8187979B2 (en) * | 2009-12-23 | 2012-05-29 | Varian Semiconductor Equipment Associates, Inc. | Workpiece patterning with plasma sheath modulation |
US8858782B2 (en) | 2010-06-30 | 2014-10-14 | Life Technologies Corporation | Ion-sensing charge-accumulation circuits and methods |
TWI539172B (zh) | 2010-06-30 | 2016-06-21 | 生命技術公司 | 用於測試離子感測場效電晶體(isfet)陣列之裝置及方法 |
JP2013540259A (ja) | 2010-06-30 | 2013-10-31 | ライフ テクノロジーズ コーポレーション | アレイ列積分器 |
US11307166B2 (en) | 2010-07-01 | 2022-04-19 | Life Technologies Corporation | Column ADC |
CN103168341B (zh) | 2010-07-03 | 2016-10-05 | 生命科技公司 | 具有轻度掺杂的排出装置的化学敏感的传感器 |
US9618475B2 (en) | 2010-09-15 | 2017-04-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
TWI584650B (zh) | 2010-09-24 | 2017-05-21 | 生命技術公司 | 配對電晶體電路 |
CN102749262B (zh) * | 2011-04-20 | 2015-04-08 | 中国石油化工股份有限公司 | 分离轻质循环油中饱和烃和芳烃的方法 |
US9970984B2 (en) | 2011-12-01 | 2018-05-15 | Life Technologies Corporation | Method and apparatus for identifying defects in a chemical sensor array |
EP2852682B1 (en) | 2012-05-21 | 2017-10-04 | Fluidigm Corporation | Single-particle analysis of particle populations |
US8786331B2 (en) | 2012-05-29 | 2014-07-22 | Life Technologies Corporation | System for reducing noise in a chemical sensor array |
CN103776940A (zh) * | 2012-10-19 | 2014-05-07 | 中国科学院电子学研究所 | 一种超大接触面积的阵列化微型气相色谱柱芯片 |
JP2015536141A (ja) * | 2012-11-01 | 2015-12-21 | ザ チャールズ スターク ドレイパー ラボラトリー インク | 生物試料のエクスビボマイクロ流体分析 |
US9080968B2 (en) | 2013-01-04 | 2015-07-14 | Life Technologies Corporation | Methods and systems for point of use removal of sacrificial material |
US9841398B2 (en) | 2013-01-08 | 2017-12-12 | Life Technologies Corporation | Methods for manufacturing well structures for low-noise chemical sensors |
US8962366B2 (en) | 2013-01-28 | 2015-02-24 | Life Technologies Corporation | Self-aligned well structures for low-noise chemical sensors |
JP5904958B2 (ja) | 2013-03-07 | 2016-04-20 | 株式会社東芝 | 半導体マイクロ分析チップ及びその製造方法 |
US8841217B1 (en) | 2013-03-13 | 2014-09-23 | Life Technologies Corporation | Chemical sensor with protruded sensor surface |
US8963216B2 (en) | 2013-03-13 | 2015-02-24 | Life Technologies Corporation | Chemical sensor with sidewall spacer sensor surface |
US9835585B2 (en) | 2013-03-15 | 2017-12-05 | Life Technologies Corporation | Chemical sensor with protruded sensor surface |
EP2972281B1 (en) | 2013-03-15 | 2023-07-26 | Life Technologies Corporation | Chemical device with thin conductive element |
JP2016510895A (ja) | 2013-03-15 | 2016-04-11 | ライフ テクノロジーズ コーポレーション | 一貫性のあるセンサ表面積を有する化学センサ |
US20140336063A1 (en) | 2013-05-09 | 2014-11-13 | Life Technologies Corporation | Windowed Sequencing |
US10458942B2 (en) | 2013-06-10 | 2019-10-29 | Life Technologies Corporation | Chemical sensor array having multiple sensors per well |
JP6151128B2 (ja) | 2013-08-12 | 2017-06-21 | 株式会社東芝 | 半導体マイクロ分析チップ及びその製造方法 |
JP6189231B2 (ja) * | 2014-02-26 | 2017-08-30 | 株式会社東芝 | 微粒子検査装置と微粒子検査システム及び微粒子検査方法 |
TW202024628A (zh) | 2014-12-18 | 2020-07-01 | 美商生命技術公司 | 用於使用大規模fet陣列量測分析物之方法及設備 |
US10077472B2 (en) | 2014-12-18 | 2018-09-18 | Life Technologies Corporation | High data rate integrated circuit with power management |
TWI756167B (zh) | 2014-12-18 | 2022-03-01 | 美商生命技術公司 | 積體電路裝置、感測器裝置及積體電路 |
US10828639B2 (en) | 2015-04-30 | 2020-11-10 | Hewlett-Packard Development Company L.P. | Target constituent location and discharge |
JP6750628B2 (ja) * | 2015-09-18 | 2020-09-02 | パナソニック株式会社 | 化学物質濃縮器および化学物質検出装置 |
DE102015118616B3 (de) * | 2015-10-30 | 2017-04-13 | Infineon Technologies Austria Ag | Latchup-fester Transistor |
US10788406B2 (en) | 2015-12-14 | 2020-09-29 | Panasonic Corporation | Chemical substance concentrator and chemical substance detector |
US9962701B2 (en) * | 2015-12-28 | 2018-05-08 | Qiagen Sciences, Llc | Flowcells with microretainers and particle separators for discrete seeding microspots |
US10603647B2 (en) * | 2016-12-01 | 2020-03-31 | Imagine Tf, Llc | Microstructure flow mixing devices |
US11628437B2 (en) | 2017-04-03 | 2023-04-18 | The Charles Stark Draper Laboratory, Inc. | Microfluidic system for evaluation of chemotherapeutic and immunotherapeutic drugs |
JP7005780B2 (ja) * | 2017-11-21 | 2022-01-24 | ビービービー インコーポレイテッド | バイオセンサ |
CN108102881A (zh) * | 2018-02-05 | 2018-06-01 | 中国科学院苏州纳米技术与纳米仿生研究所 | 具有微结构阵列的微流控芯片及核酸固相纯化提取方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09504362A (ja) * | 1993-06-08 | 1997-04-28 | ブリティッシュ・テクノロジー・グループ・ユーエスエイ・インコーポレーテッド | 巨大分子及び細胞の分画用のマイクロリソグラフ配列 |
JPH10506991A (ja) * | 1994-09-30 | 1998-07-07 | アボツト・ラボラトリーズ | 構造体アレイを利用して分析物を捕捉する装置および方法 |
US6027623A (en) * | 1998-04-22 | 2000-02-22 | Toyo Technologies, Inc. | Device and method for electrophoretic fraction |
JP2001515216A (ja) * | 1997-08-13 | 2001-09-18 | シーフィード | 流体試料を操作するための微小構造体 |
JP2002502597A (ja) * | 1998-02-05 | 2002-01-29 | アクレイラ バイオサイエンシズ,インコーポレイティド | 統合ミクロ流体装置 |
WO2002023180A1 (fr) * | 2000-09-18 | 2002-03-21 | Hitachi, Ltd. | Extracteur et analyseur chimique |
JP2002524755A (ja) * | 1998-09-17 | 2002-08-06 | アドヴィオン バイオサイエンシィズ インコーポレイテッド | 一体化モノリシックマイクロ加工したエレクトロスプレーと液体クロマトグラフィーのシステムおよび方法 |
JP2002292600A (ja) * | 2001-03-30 | 2002-10-08 | Mitsui Chemicals Inc | マイクロ配管およびその製造方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2621974A1 (de) * | 1976-05-18 | 1977-11-24 | Max Planck Gesellschaft | Verfahren zur herstellung eines zur kovalenten bindung mit biologisch aktivem material befaehigten traegermaterials |
US6368871B1 (en) * | 1997-08-13 | 2002-04-09 | Cepheid | Non-planar microstructures for manipulation of fluid samples |
US6289286B1 (en) * | 1998-05-29 | 2001-09-11 | Biacore Ab | Surface regeneration of biosensors and characterization of biomolecules associated therewith |
ATE335202T1 (de) * | 2000-03-16 | 2006-08-15 | Biacore Ab | Verfahren zur erfassung von analyten, die aus oberflächengebundenen liganden eluiert werden |
-
2003
- 2003-11-28 JP JP2004556860A patent/JPWO2004051231A1/ja active Pending
- 2003-11-28 WO PCT/JP2003/015260 patent/WO2004051231A1/ja active Application Filing
- 2003-11-28 US US10/536,798 patent/US20060000772A1/en not_active Abandoned
- 2003-11-28 CN CNA2003801046411A patent/CN1720438A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09504362A (ja) * | 1993-06-08 | 1997-04-28 | ブリティッシュ・テクノロジー・グループ・ユーエスエイ・インコーポレーテッド | 巨大分子及び細胞の分画用のマイクロリソグラフ配列 |
JPH10506991A (ja) * | 1994-09-30 | 1998-07-07 | アボツト・ラボラトリーズ | 構造体アレイを利用して分析物を捕捉する装置および方法 |
JP2001515216A (ja) * | 1997-08-13 | 2001-09-18 | シーフィード | 流体試料を操作するための微小構造体 |
JP2002502597A (ja) * | 1998-02-05 | 2002-01-29 | アクレイラ バイオサイエンシズ,インコーポレイティド | 統合ミクロ流体装置 |
US6027623A (en) * | 1998-04-22 | 2000-02-22 | Toyo Technologies, Inc. | Device and method for electrophoretic fraction |
JP2002524755A (ja) * | 1998-09-17 | 2002-08-06 | アドヴィオン バイオサイエンシィズ インコーポレイテッド | 一体化モノリシックマイクロ加工したエレクトロスプレーと液体クロマトグラフィーのシステムおよび方法 |
WO2002023180A1 (fr) * | 2000-09-18 | 2002-03-21 | Hitachi, Ltd. | Extracteur et analyseur chimique |
JP2002292600A (ja) * | 2001-03-30 | 2002-10-08 | Mitsui Chemicals Inc | マイクロ配管およびその製造方法 |
Non-Patent Citations (3)
Title |
---|
Chia-Fu Chou et al. Proceedings of the National Academy of Sciences of the United States of America, 23 November 1999, Vol. 96, No. 24, pages 13762-13765 * |
M. Baba, et al. Sixth International Conference on Miniaturized Chemical and Biochemical Analysis Systems (Micro Total Analysis Systems 2002) 03 November 2002, Vol. 2, pages 763-765 * |
SANO, et al. Dai 63 Kai Extended Abstracts; The Japan Society of Applied Physics, separate Vol. 3, 24 September 2002, page 1146 (25a-R-8) * |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005257544A (ja) * | 2004-03-12 | 2005-09-22 | Gl Sciences Inc | マイクロチップ |
EP1815244A1 (en) * | 2004-11-11 | 2007-08-08 | Agency for Science, Technology and Research | Cell culture device |
EP1815244A4 (en) * | 2004-11-11 | 2009-07-22 | Agency Science Tech & Res | DEVICE FOR CULTURING CELLS |
US20060160243A1 (en) | 2005-01-18 | 2006-07-20 | Biocept, Inc. | Recovery of rare cells using a microchannel apparatus with patterned posts |
US10369568B2 (en) | 2005-01-18 | 2019-08-06 | Biocept, Inc. | Cell separation using microchannel having patterned posts |
US9212977B2 (en) | 2005-01-18 | 2015-12-15 | Biocept, Inc. | Cell separation using microchannel having patterned posts |
US8158410B2 (en) | 2005-01-18 | 2012-04-17 | Biocept, Inc. | Recovery of rare cells using a microchannel apparatus with patterned posts |
JP2008533485A (ja) * | 2005-03-18 | 2008-08-21 | キヤノン株式会社 | 構造体、分離素子、分離装置、捕捉素子、検出装置、及びその製造方法、ならびに標的物質の分離方法及び検出方法 |
WO2006098502A1 (en) * | 2005-03-18 | 2006-09-21 | Canon Kabushiki Kaisha | Pillar structure for separating or capturing target substance |
JP2006296427A (ja) * | 2005-04-15 | 2006-11-02 | Samsung Electronics Co Ltd | 疎水性固体支持体を利用した細胞分離方法 |
US7695956B2 (en) | 2006-01-12 | 2010-04-13 | Biocept, Inc. | Device for cell separation and analysis and method of using |
WO2007135826A1 (ja) * | 2006-05-23 | 2007-11-29 | The University Of Electro-Communications | 目的物質の塗布方法、及びマイクロ化学チップ |
JP2007315754A (ja) * | 2006-05-23 | 2007-12-06 | Univ Of Electro-Communications | 目的物質の塗布方法、及びマイクロ化学チップ |
US7811829B2 (en) * | 2006-06-08 | 2010-10-12 | Canon Kabushiki Kaisha | Measuring probe and production process thereof |
WO2008011486A3 (en) * | 2006-07-19 | 2008-10-23 | Biocept Inc | Detection or isolation of target molecules using a microchannel apparatus |
JP2009544043A (ja) * | 2006-07-19 | 2009-12-10 | バイオセプト インコーポレイティッド | マイクロチャネル装置を用いた標的分子の検出または単離 |
KR101472599B1 (ko) * | 2006-07-19 | 2014-12-15 | 바이오셉트 인코포레이티드 | 마이크로채널 장치를 이용한 표적 분자의 검출 또는 단리 |
WO2008020593A1 (fr) * | 2006-08-14 | 2008-02-21 | Tokyo Electron Limited | colonne pour chromatographie et son procédé de fabrication |
JP2008045966A (ja) * | 2006-08-14 | 2008-02-28 | Tokyo Electron Ltd | クロマトグラフィ用のカラム及びその製造方法 |
JP2008048735A (ja) * | 2006-08-21 | 2008-03-06 | Samsung Electronics Co Ltd | 非平面状の固体支持体を用いた微生物の分離方法及び分離装置 |
US8557564B2 (en) | 2006-08-21 | 2013-10-15 | Samsung Electronics Co., Ltd. | Method of separating microorganism using nonplanar solid substrate and device for separating microorganism using the same |
US8158411B2 (en) | 2006-08-21 | 2012-04-17 | Samsung Electronics Co., Ltd. | Method of separating microorganism using nonplanar solid substrate and device for separating microorganism using the same |
JP2008249538A (ja) * | 2007-03-30 | 2008-10-16 | Seiko Epson Corp | 検出素子 |
US8389277B2 (en) | 2007-10-11 | 2013-03-05 | Agency For Science, Technology And Research | Forming cell structure with transient linker in cage |
JP2011500018A (ja) * | 2007-10-11 | 2011-01-06 | エージェンシー フォー サイエンス, テクノロジー アンド リサーチ | ケージ中で一時的リンカーを用いて細胞構造体を形成する方法 |
JP2011520117A (ja) * | 2008-05-06 | 2011-07-14 | コミサリア ア レネルジー アトミック エ オ ゼネルジー アルテルナティブ | 流体から生体分子を分離する装置 |
JP2010078482A (ja) * | 2008-09-26 | 2010-04-08 | Fujifilm Corp | 質量分析用基板および質量分析方法 |
JP2010236945A (ja) * | 2009-03-30 | 2010-10-21 | Sharp Corp | 被検体物質の固定化方法およびマイクロ分析装置 |
JP2011174856A (ja) * | 2010-02-25 | 2011-09-08 | Tokyo Electron Ltd | クロマトグラフィー用カラム、その製造方法、および分析装置 |
WO2011104990A1 (ja) * | 2010-02-25 | 2011-09-01 | 東京エレクトロン株式会社 | クロマトグラフィー用カラム、その製造方法、および分析装置 |
JP2011220768A (ja) * | 2010-04-07 | 2011-11-04 | Sharp Corp | 分析装置および分析方法 |
JP2015099031A (ja) * | 2013-11-18 | 2015-05-28 | 株式会社東芝 | 半導体マイクロ分析チップ及びその製造方法 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2004051231A1 (ja) | 2006-04-06 |
US20060000772A1 (en) | 2006-01-05 |
CN1720438A (zh) | 2006-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004051231A1 (ja) | 分離装置および分離方法 | |
KR101329445B1 (ko) | 동전기적 농축 장치 및 그의 사용 방법 | |
US7098450B2 (en) | Apparatus and method for dispensing a sample | |
JP4074921B2 (ja) | 質量分析システムおよび分析方法 | |
US20060219558A1 (en) | Improved Methods and Devices for Concentration and Fractionation of Analytes for Chemical Analysis including Matrix-Assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry (MS) | |
Ekström et al. | On‐chip microextraction for proteomic sample preparation of in‐gel digests | |
US20090071834A1 (en) | Methods and Devices for Concentration and Fractionation of Analytes for Chemical Analysis Including Matrix-Assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry (MS) | |
JP5289452B2 (ja) | 動電学的な濃縮装置及びその使用方法 | |
US8329115B2 (en) | Nanofluidic preconcentration device in an open environment | |
US20040256318A1 (en) | Separating device, analysis system separation method and method of manufacture of separating device | |
Wang et al. | Sample pre-treatment techniques for use with ICP-MS hyphenated techniques for elemental speciation in biological samples | |
JP7099965B2 (ja) | 吸着材料を使用して試料から抽出された分析物を分析するためのシステムおよび方法 | |
JP5462919B2 (ja) | 基材の修飾方法 | |
JP4432778B2 (ja) | マイクロチップおよび質量分析システム | |
WO2004051228A1 (ja) | マイクロチップならびにこれを用いた送液方法、質量分析システム | |
Li et al. | Affinity depletion of albumin from human cerebrospinal fluid using Cibacron-blue-3G-A-derivatized photopatterned copolymer in a microfluidic device | |
JP2004150841A (ja) | 生体物質精製方法および生体物質精製用キットおよび生体物質分析システム | |
WO2004051234A1 (ja) | 試料乾燥装置およびこれを用いた質量分析装置、質量分析システム | |
CN101175546A (zh) | 用于包括基质辅助激光解吸电离质谱的化学分析中的改进的分析物的富集和分级方法及器件 | |
US20050133371A1 (en) | Apparatus and method for Edman degradation on a microfluidic device utilizing an electroosmotic flow pump | |
Chen et al. | Microfluidic bioreactors for highly efficient proteolysis | |
Hou | Centrifugal Microfluidic System for Biochemical Applications | |
JP2004301549A (ja) | 分子吸着放出装置及び分子吸着放出方法 | |
Li | Towards multidimensional separations of cerebrospinal fluid proteins in microfluidic devices | |
JP2008128834A (ja) | キャリアタンパク質に結合した分子の検出方法、検出キット及び検出装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA CN JP US |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004556860 Country of ref document: JP |
|
ENP | Entry into the national phase |
Ref document number: 2006000772 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10536798 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038A46411 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 10536798 Country of ref document: US |